FOEHR MATTHEW W

The estimated Net Worth of FOEHR MATTHEW W is at least $22 Million dollars dollars as of 06/23/2021. FOEHR MATTHEW W is the President and COO of Ligand Pharmaceuticals Inc. FOEHR MATTHEW W owns over 168,198 shares of Ligand Pharmaceuticals Inc stock worth over $22 Million dollars . FOEHR MATTHEW W is the Director of Ritter Pharmaceuticals Inc. FOEHR MATTHEW W owns over 930 shares of Ritter Pharmaceuticals Inc stock worth over $418.50. FOEHR MATTHEW W is the Director of Viking Therapeutics Inc. FOEHR MATTHEW W owns over 66,250 shares of Viking Therapeutics Inc stock worth over $402,137.50.

FOEHR MATTHEW W mailing address: 11119 NORTH TORREY PINES RD #200 LA JOLLA CA 92037

Insider Roles

Name Transaction Date Position
Ligand Pharmaceuticals Inc 2020-08-21 officer: President and COO
Viking Therapeutics Inc 2020-06-30 director
Ritter Pharmaceuticals Inc 2020-01-21 director
EMBED
SAVE

FOEHR MATTHEW W trading performance

Average Relative Return

28.02%

Average relative return per transaction

Outperforming Transactions

62%

8 out of 13 outperforming transactions.
Each transaction is measured over a period and compared to .

FOEHR MATTHEW W trading performance analysis

1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -3.26 -9.28 -6.14 28.02 137.34 178.2
Relative Return to S&P 500(%) -4.48 -10.94 -12 17.93 114.64 146.54

Foehr Matthew W trading transactions

Ticker Company Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost(000) Final Share Price Change Since Insider Trade (%) Dividend Yield % PE Ratio Market Cap ($M)
VKTX
Viking Therapeutics Inc
$6.07
FOEHR MATTHEW W
Director
2021-06-10 Buy
20,000
43.24%
$5.69
$113.80
66,250
6.68%
0
0
474.07
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2021-02-04 Sell
44,547
-20.94%
$176.86
$7,878.58
168,198
-26.72%
0
56.35
2,158.28
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2020-08-24 Sell
7,303
-4.49%
$112.86
$824.22
155,413
14.84%
0
56.35
2,158.28
VKTX
Viking Therapeutics Inc
$6.07
FOEHR MATTHEW W
Director
2020-06-30 Sell
13,000
-33.12%
$7.35
$95.55
26,250
-17.41%
0
0
474.07
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2020-02-27 Sell
7,225
-4.44%
$110
$794.75
155,449
17.83%
0
56.35
2,158.28
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2020-02-14 Sell
7,225
-4.49%
$95.84
$692.44
153,743
35.24%
0
56.35
2,158.28
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2018-10-01 Sell
12,000
-10.22%
$273.88
$3,286.56
105,388
-52.68%
0
56.35
2,158.28
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2018-09-04 Sell
12,000
-10.41%
$255.01
$3,060.12
103,300
-49.17%
0
56.35
2,158.28
RTTR
Ritter Pharmaceuticals Inc
$0.45
FOEHR MATTHEW W
Director
2018-08-17 Buy
19,751
56.43%
$2.04
$40.29
2,190.04
-77.94%
0
0
0.83
RTTR
Ritter Pharmaceuticals Inc
$0.45
FOEHR MATTHEW W
Director
2018-08-17 Buy
19,751
564.31%
$2.04
$40.29
930.04
-77.94%
0
0
0.83
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2018-05-10 Sell
8,881
-7.99%
$167.63
$1,488.72
102,256
-22.68%
0
56.35
2,158.28
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2018-02-23 Sell
5,444
-5.38%
$152.98
$832.82
95,835
-15.28%
0
56.35
2,158.28
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2017-08-09 Sell
6,100
-5.99%
$127.51
$777.81
95,770
1.65%
0
56.35
2,158.28
RTTR
Ritter Pharmaceuticals Inc
$0.45
FOEHR MATTHEW W
Director
2017-05-18 Buy
18,000
105.88%
$0.62
$11.16
140
-27.42%
0
0
0.83
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2017-05-12 Sell
5,621
-5.59%
$112.20
$630.68
94,920
15.52%
0
56.35
2,158.28
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2017-03-02 Sell
6,879
-6.91%
$103.39
$711.22
92,720
25.36%
0
56.35
2,158.28
VKTX
Viking Therapeutics Inc
$6.07
FOEHR MATTHEW W
Director
2016-11-15 Buy
13,000
49.52%
$1.21
$15.73
39,250
401.65%
0
0
474.07
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2016-08-05 Sell
12,500
-13.08%
$122.14
$1,526.75
83,037
6.12%
0
56.35
2,158.28
VKTX
Viking Therapeutics Inc
$6.07
FOEHR MATTHEW W
Director
2016-04-13 Buy
20,000
320%
$1.24
$24.80
26,250
389.52%
0
0
474.07
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2016-03-17 Sell
6,400
-7.50%
$96.70
$618.88
78,912
34.03%
0
56.35
2,158.28
RTTR
Ritter Pharmaceuticals Inc
$0.45
FOEHR MATTHEW W
Director
2016-01-08 Buy
13,000
325%
$1.64
$21.32
68
-72.56%
0
0
0.83
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2015-06-26 Sell
12,500
-14.68%
$100.97
$1,262.12
72,628
28.36%
0
56.35
2,158.28
RTTR
Ritter Pharmaceuticals Inc
$0.45
FOEHR MATTHEW W
Director
2015-06-24 Buy
4,000
100%
$5
$20
16
-91%
0
0
0.83
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
President and COO
2015-06-22 Sell
23,046
-24.73%
$96.45
$2,222.79
70,128
34.38%
0
56.35
2,158.28
VKTX
Viking Therapeutics Inc
$6.07
FOEHR MATTHEW W
Director
2015-05-04 Buy
6,250
100%
$8
$50
6,250
-24.13%
0
0
474.07
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
EVP and COO
2014-02-14 Sell
22,500
-29.62%
$79.54
$1,789.65
53,457
62.95%
0
56.35
2,158.28
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
EVP and COO
2013-12-12 Sell
6,000
-11.78%
$53.40
$320.40
44,929
142.72%
0
56.35
2,158.28
LGND
Ligand Pharmaceuticals Inc
$129.61
FOEHR MATTHEW W
EVP and COO
2013-06-28 Buy
1,059
2.41%
$17.36
$18.38
44,929
646.60%
0
56.35
2,158.28
Total 28
  • 1

FOEHR MATTHEW W personal network

Name Position Linked company